Drug Type Small molecule drug |
Synonyms- |
Target |
Action degraders |
Mechanism GSPT1 degraders(G1 to S phase transition 1 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Exanthema | Discovery | - | 14 Mar 2025 | |
Immune System Diseases | Discovery | - | 14 Mar 2025 | |
Myeloproliferative Disorders | Discovery | - | 14 Mar 2025 | |
Neoplasms | Discovery | - | 14 Mar 2025 | |
Nervous System Diseases | Discovery | - | 14 Mar 2025 | |
Other Diseases | Discovery | - | 14 Mar 2025 | |
Respiratory Diseases | Discovery | - | 14 Mar 2025 | |
Uveitis | Discovery | - | 14 Mar 2025 |